MiMedx Group, Inc. (MDXG)
NASDAQ·Healthcare·Biotechnology
$4.21
-1.52%
Mkt Cap $601.99M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (6 analysts)
$8.50
Range $7.00 – $10.00
Implied Upside
+102.1%
Consensus $8.50 vs current $4.21
NASDAQ·Healthcare·Biotechnology
$4.21
-1.52%
Mkt Cap $601.99M
Buy
2
Hold
0
Sell
0
Price Target (6 analysts)
$8.50
Range $7.00 – $10.00
+102.1%
Consensus $8.50 vs current $4.21